Disease-modifying drugs in Alzheimer’s disease

Por Ghezzi, Laura, Scarpini, Elio, Galimberti, Daniela
Publicado em 2013

Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

Por Norris, Susan L, Zhang, Xuanping, Avenell, Alison, Gregg, Edward, Schmid, Christopher H, Lau, Joseph
Publicado no Cochrane Database Syst Rev (2005)

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics

Por Galmarini, C M, Kamath, K, Vanier-Viornery, A, Hervieu, V, Peiller, E, Falette, N, Puisieux, A, Ann Jordan, M, Dumontet, C
Publicado em 2003

Effect of a Modest Weight Loss in Normalizing Blood Pressure in Obese Subjects on Antihypertensive Drugs

Por Gilardini, Luisa, Redaelli, Gabriella, Croci, Marina, Conti, Antonio, Pasqualinotto, Lucia, Invitti, Cecilia
Publicado no Obes Facts (2016)

Drug discovery and development for neglected diseases: the DNDi model

Por Chatelain, Eric, Ioset, Jean-Robert
Publicado em 2011

Current and emerging drugs for the treatment of inflammatory bowel disease

Por Triantafillidis, John K, Merikas, Emmanuel, Georgopoulos, Filippos
Publicado em 2011

Resveratrol as a potential therapeutic drug for respiratory system diseases

Por Zhu, Xiao-dan, Lei, Xiao-ping, Dong, Wen-bin
Publicado no Drug Des Devel Ther (2017)

Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2

Por Ammoun, Sylwia, Schmid, Marei Caroline, Triner, Joceline, Manley, Paul, Hanemann, Clemens Oliver
Publicado em 2011

Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating...

Por Trindade-da-Silva, Carlos Antonio, Bettaieb, Ahmed, Napimoga, Marcelo Henrique, Lee, Kin Sing Stephen, Inceoglu, Bora, Ueira-Vieira, Carlos, Bruun, Donald, Goswami, Sumanta Kumar, Haj, Fawaz G., Hammock, Bruce D.
Publicado no J Pharmacol Exp Ther (2017)

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

Por Heerspink, H J Lambers, de Zeeuw, D, Wie, L, Leslie, B, List, J
Publicado em 2013

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas

Por Blakeley, Jaishri O., Ye, Xiaobu, Duda, Dan G., Halpin, Chris F., Bergner, Amanda L., Muzikansky, Alona, Merker, Vanessa L., Gerstner, Elizabeth R., Fayad, Laura M., Ahlawat, Shivani, Jacobs, Michael A., Jain, Rakesh K., Zalewski, Christopher, Dombi, Eva, Widemann, Brigitte C., Plotkin, Scott R.
Publicado no J Clin Oncol (2016)

Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes

Por Michelangelo Paci, Simona Casini, Milena Bellin, Jari Hyttinen, Stefano Severi
Publicado em 2018-11-01

Translational challenges of animal models in Chagas disease drug development: a review

Por Chatelain, Eric, Konar, Nandini
Publicado no Drug Des Devel Ther (2015)

Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs

Por Yoshihito Ishida, Hideshi Kawakami, Hiroyuki Kitajima, Ayaka Nishiyama, Yoshiki Sasai, Haruhisa Inoue, Keiko Muguruma
Publicado em 2016-11-01

Screening for Microtubule-Disrupting Antifungal Agents by Using a Mitotic-Arrest Mutant of Aspergillus nidulans and Novel Action of Phenylalanine Derivatives Accompanying Tubulin Loss

Por Kiso, Tetsuo, Fujita, Ken-Ichi, Ping, Xu, Tanaka, Toshio, Taniguchi, Makoto
Publicado em 2004

IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria

Por Baumgart, Meike, Luder, Kerstin, Grover, Shipra, Gätgens, Cornelia, Besra, Gurdyal S, Frunzke, Julia
Publicado em 2013

Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type

Por Sa, Juliana M, Twu, Olivia
Publicado em 2010

p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression...

Por Li, Xiye, Chen, Hongsai, Xue, Lu, Pang, Xiuhong, Zhang, Xiaoman, Zhu, Zhengjie, Zhu, Weidong, Wang, Zhaoyan, Wu, Hao
Publicado no Oncol Lett (2017)

Efficacy of canagliflozin combined with antidiabetic drugs in treating type 2 diabetes mellitus: Meta‐analysis of randomized control trials

Por Meng, Qi, Shen, Yun, Liu, Dajin, Jiang, Fei
Publicado no J Diabetes Investig (2015)

... In Vitro Susceptibilities of Wild and Drug Resistant Leishmania donovani Amastigote Stages...

Por Mondal, Subhasish, Roy, Partha, Das, Suvadra, Halder, Asim, Mukherjee, Arup, Bera, Tanmoy
Publicado em 2013